As we head into the new year, now is the time to look back on the activity seen in the pharma space in 2025 and consider what ...

From tariffs and onshoring to MFN, the US has seen significant policy developments - but how will these impact pharma in 2026?

With the latest batch’s agreements, only three out of the 17 drugmakers initially targeted by Trump have not signed pricing ...

Mandy Vink, VP of Business Development at Codexis, explains how the company leverages over 20 years of expertise in small-molecule APIs to advance biocatalysis across pharma.

Halozyme Therapeutics has been busy. While fighting a patent dispute with Merck & Co. and navigating the impact of the Inflation Reduction Act (IRA), the company has penned an acquisition of fellow ...

As pharmaceutical markets become more specialized and competitive, commercial and medical affairs teams must use technology and collaboration to make faster, better-informed decisions, Lance Hill, ...

Based on research and analysis of the global microecology market, as well as the evaluation of relevant companies in the ...